Strides Arcolab has received US FDA approval for Clindamycin Injection, USP, an antibiotic used to treat bacterial infections. Clindamycin Injection will be available in three single dose vial sizes and in pharmacy bulk packaging. As with all products in Strides- Sagent JV, Clindamycin features the prevent IV measures packaging and labeling designed to aid in reduction of the medication errors.
According to the IMS, the 2011 US market for injectable Clindamycin approximates to $65 million. The product is expected to be launched in early 2012. Clindamycin is the twelfth product approved under the Sagent-Strides partnership. The company is developing and supplying more than 25 injectables products for the USA market which will be marketed by Sagent.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: